Navigation Links
Study finds mammography screening reduces breast cancer mortality
Date:6/27/2011

OAK BROOK, Ill. Breast cancer screening with mammography results in a significant reduction in breast cancer mortality, according to long-term follow-up results of a large-scale Swedish trial. The results are published online in the journal Radiology.

"Mammographic screening confers a substantial relative and absolute reduction in breast cancer mortality risk in the long-term," said Stephen W. Duffy, M.Sc., professor of cancer screening at Queen Mary, University of London. "For every 1,000 to 1,500 mammograms, one breast cancer death is prevented."

The Swedish Two-County Trial of mammographic screening was the first breast cancer screening trial to show a reduction in breast cancer mortality from screening with mammography alone. The trial randomized 133,065 women into two groups, one that received an invitation to screening and another that received usual care. At the conclusion of the study, there were 30 percent fewer breast cancer deaths among all women (attenders and non-attenders) in the group invited to undergo screening. The screening phase of the trial lasted approximately seven years. Women between the ages of 40 and 49 were screened, on average, every 24 months, and women age 50 to 74 were screened, on average, every 33 months.

For the current study, nearly three decades after the beginning of the trial, the researchers analyzed the original data and the follow-up data to estimate the long-term effect of mammography screening on breast cancer mortality. At 29 years, this represents the longest recorded follow-up period for a mammography screening trial.

Case status and cause of death were determined by local trial end point committees and, independently, by an external committee. Mortality analysis at follow up showed a reduction in the breast cancer mortality rate in the screening population, similar to the original trial results. But while the relative effect of screening on breast cancer mortality remained stable over the follow-up period, the absolute benefit in terms of lives saved increased with longer follow-up times. At 29 years of follow-up, the estimated number of women needed to undergo screening every 2 or 3 years over a seven-year period to prevent one breast cancer death ranged from 414 to 519.

According to the researchers, evaluation of the full impact of screening mammography requires follow-up times exceeding 15 to 20 years, because the observed number of breast cancer deaths prevented increases with the passage of time.

"Most of the deaths prevented would have occurred more than 10 years after the screening started," Duffy said. "This indicates that the long-term benefits of screening in terms of deaths prevented are more than double those often quoted for short-term follow-up."

These new data add to the evidence on the long-term benefits of regular mammography screening, and should be included in the discussions between women and doctors about what to expect from breast cancer screening.

"Unfortunately, we cannot know for certain who will and who will not develop breast cancer," Duffy said. "But if you undergo a recommended screening regimen, and you are diagnosed with breast cancer at an early stage, chances are very good that it will be successfully treated."


'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. Study shows long-term benefits of breast screening
2. Black members of Adventist church defy health disparities, study shows
3. Hospitals in U.S. Territories Have Higher Death Rates: Study
4. Study finds peat wildfire smoke linked to heart failure risk
5. Study reveals possible brain damage in young adult binge-drinkers
6. Study: Most parents unaware of teen workplace risks
7. Calories, Not Protein or Carbs, Are Key to Weight Loss: Study
8. Pregnancy Safe for Most Women With MS: Study
9. Study finds pregnancy safe in multiple sclerosis
10. Genetic study shows that low body fat may not lower risk for heart disease and diabetes
11. After Diabetes Diagnosis, Concentrate on Dietary Changes, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... ... 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace ... help but be heartened by the industry’s current surge. But another thing that unifies ... smell.” At last they can simply, safely and effectively end their aroma anguish ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... , April 24, 2017 Solentim, ... today announced the addition of a major new ... In-situ Plate Seeding,). The VIPS has been developed ... 384 well microplates as part of the process ... offers a simple and more reliable solution when ...
(Date:4/20/2017)... PLANO, Texas , April 20, 2017  Vivify ... via mobile devices, has been awarded a very significant ... care via EMRs to continual care via digital health. ... of key intellectual property and further secures Vivify,s position ... Vivify, launched in 2009, was the first company to ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
Breaking Medicine Technology: